“Part way into the ‘24 selling season, this momentum continues with strong client additions.”

In context

“digit growth at both Optum and UnitedHealthcare. OptumHealth revenues grew by 36% to $23.9 billion, driven by an increase in the number of patients served, a growing mix of patients with more complex needs and the expanding scope of care services we can offer. Operating margins reflect the higher care activity patterns we have discussed with seniors comprising a significant majority of value-based patients served. OptumRx revenues grew by 15%, surpassing $28 billion, driven by continued new customer wins and strong double-digit growth across our specialty, infusion, and community pharmacies. Script growth of nearly 7% reflects continued demand for our affordable solutions that give customers choice and simplify the pharmacy experience, such as biosimilar access and digital pharmacy tools. Part way into the ‘24 selling season, this momentum continues with strong client additions. OptumInsight revenues grew 42% to nearly $4.7 billion. The revenue backlog reached over $31 billion, an increase of $8 billion over last year, in part due to the addition of Change Healthcare. The integration and investment activities discussed on previous calls have gone well and are setting the stage for the next phase of growth for OptumInsight. Turning to UnitedHealthcare. Our commercial business added nearly 500,000 people in the first-half and continues its growth with the ‘24 selling season indications tracking favorably. Within our public sector programs, we continue to expect growth of over 900,000 Medicare Advantage members this year. And our Medicaid performance remains strong, as we continue to support states as they initiate redeterminations. Comprehensive outreach efforts to”